Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs SHREE GANESH REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA SHREE GANESH REMEDIES GRANULES INDIA/
SHREE GANESH REMEDIES
 
P/E (TTM) x 26.4 39.0 67.6% View Chart
P/BV x 3.7 9.6 38.4% View Chart
Dividend Yield % 0.3 0.1 465.6%  

Financials

 GRANULES INDIA   SHREE GANESH REMEDIES
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
SHREE GANESH REMEDIES
Mar-23
GRANULES INDIA/
SHREE GANESH REMEDIES
5-Yr Chart
Click to enlarge
High Rs381349 109.2%   
Low Rs227213 106.5%   
Sales per share (Unadj.) Rs186.470.2 265.5%  
Earnings per share (Unadj.) Rs21.313.2 161.1%  
Cash flow per share (Unadj.) Rs29.016.1 179.4%  
Dividends per share (Unadj.) Rs1.500.50 300.0%  
Avg Dividend yield %0.50.2 277.3%  
Book value per share (Unadj.) Rs116.469.2 168.2%  
Shares outstanding (eoy) m242.0412.85 1,883.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.64.0 40.8%   
Avg P/E ratio x14.221.2 67.2%  
P/CF ratio (eoy) x10.517.4 60.3%  
Price / Book Value ratio x2.64.1 64.4%  
Dividend payout %7.03.8 186.2%   
Avg Mkt Cap Rs m73,6113,611 2,038.3%   
No. of employees `000NANA-   
Total wages/salary Rs m4,20339 10,720.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,119902 5,001.0%  
Other income Rs m14332 451.4%   
Total revenues Rs m45,262934 4,846.9%   
Gross profit Rs m9,133233 3,926.5%  
Depreciation Rs m1,84537 4,952.9%   
Interest Rs m5591 48,218.1%   
Profit before tax Rs m6,872226 3,042.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,70656 3,065.7%   
Profit after tax Rs m5,166170 3,035.2%  
Gross profit margin %20.225.8 78.5%  
Effective tax rate %24.824.6 100.8%   
Net profit margin %11.418.9 60.7%  
BALANCE SHEET DATA
Current assets Rs m25,741643 4,003.8%   
Current liabilities Rs m18,135237 7,639.0%   
Net working cap to sales %16.944.9 37.5%  
Current ratio x1.42.7 52.4%  
Inventory Days Days146 248.2%  
Debtors Days Days771,130 6.8%  
Net fixed assets Rs m23,290795 2,931.1%   
Share capital Rs m242125 193.5%   
"Free" reserves Rs m27,927764 3,654.1%   
Net worth Rs m28,169889 3,167.3%   
Long term debt Rs m1,486309 480.6%   
Total assets Rs m49,0311,437 3,410.9%  
Interest coverage x13.3195.7 6.8%   
Debt to equity ratio x0.10.3 15.2%  
Sales to assets ratio x0.90.6 146.6%   
Return on assets %11.711.9 98.0%  
Return on equity %18.319.1 95.8%  
Return on capital %25.118.9 132.3%  
Exports to sales %81.068.6 118.1%   
Imports to sales %31.323.7 132.3%   
Exports (fob) Rs m36,526619 5,904.6%   
Imports (cif) Rs m14,120213 6,614.6%   
Fx inflow Rs m36,526619 5,904.6%   
Fx outflow Rs m14,120213 6,614.6%   
Net fx Rs m22,406405 5,530.5%   
CASH FLOW
From Operations Rs m7,387170 4,342.8%  
From Investments Rs m-1,914-536 357.2%  
From Financial Activity Rs m-4,403413 -1,065.3%  
Net Cashflow Rs m1,06848 2,241.3%  

Share Holding

Indian Promoters % 41.6 69.3 60.0%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 28.9 0.0 -  
FIIs % 18.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 30.7 189.2%  
Shareholders   190,691 7,518 2,536.5%  
Pledged promoter(s) holding % 4.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs SHREE GANESH REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs SHREE GANESH REMEDIES Share Price Performance

Period GRANULES INDIA SHREE GANESH REMEDIES S&P BSE HEALTHCARE
1-Day 0.03% 0.53% 1.18%
1-Month -6.51% -1.72% -0.75%
1-Year 58.65% 176.31% 61.82%
3-Year CAGR 11.62% 35.46% 18.16%
5-Year CAGR 29.84% 75.17% 19.79%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the SHREE GANESH REMEDIES share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of SHREE GANESH REMEDIES the stake stands at 69.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of SHREE GANESH REMEDIES .

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

SHREE GANESH REMEDIES paid Rs 0.5, and its dividend payout ratio stood at 3.8%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of SHREE GANESH REMEDIES .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.